-
???insights.card.a11y.category??? news News
How Novo Nordisk’s ‘select’ study results could shake up the obesity drug space
-
???insights.card.a11y.category??? news News
Novo and Eli Lilly stocks could go higher if they show even better data than we think: Mizuho’s Holz
-
???insights.card.a11y.category??? news News
Investment bankers see dealmaking lull storing pent-up demand
-
???insights.card.a11y.category??? news News
You own Robinhood ‘for the future’, says Mizuho’s Dan Dolev
-
???insights.card.a11y.category??? news News
Top Calls: Uber delivers mixed 3Q report, outlook
-
???insights.card.a11y.category??? news News
Vikram Malhotra on Bloomberg Markets (Starts at 24:23)
-
???insights.card.a11y.category??? press-release Press Releases
Mizuho Americas hires John Roberts as managing director and senior equity research analyst to cover chemicals and packaging
-
???insights.card.a11y.category??? news News
Mounjaro remains the single largest driver for Eli Lilly stock in the near term: Mizuho’s Jared Holz
-
???insights.card.a11y.category??? news News
AMD is starting to execute well in the artificial intelligence market, says Mizuho’s Rakesh